(HealthDay)—An experimental drug shows promise in treating respiratory syncytial virus (RSV), a leading cause of pneumonia in infants, researchers report.
Aug 21, 2014
5 / 5 (2) | 0
A specialized subset of lung cells can shake flu infection, yet they remain stamped with an inflammatory gene signature that wreaks havoc in the lung, according to a study published in The Journal of Experimental Me ...
Aug 18, 2014
5 / 5 (1) | 0